000 01680 a2200493 4500
005 20250514054613.0
264 0 _c20030402
008 200304s 0 0 eng d
022 _a1398-5647
024 7 _a10.1034/j.1399-5618.2002.02228.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHummel, Barbara
245 0 0 _aAcute antimanic efficacy and safety of oxcarbazepine in an open trial with an on-off-on design.
_h[electronic resource]
260 _bBipolar disorders
_cDec 2002
300 _a412-7 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAnticonvulsants
_xadverse effects
650 0 4 _aBipolar Disorder
_xdrug therapy
650 0 4 _aCarbamazepine
_xadverse effects
650 0 4 _aCross-Over Studies
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOxcarbazepine
650 0 4 _aPilot Projects
650 0 4 _aPsychiatric Status Rating Scales
650 0 4 _aPsychometrics
_xmethods
650 0 4 _aTime Factors
650 0 4 _aTreatment Outcome
700 1 _aWalden, Joerg
700 1 _aStampfer, Robert
700 1 _aDittmann, Sandra
700 1 _aAmann, Benedikt
700 1 _aSterr, Andrea
700 1 _aSchaefer, Martin
700 1 _aFrye, Mark A
700 1 _aGrunze, Heinz
773 0 _tBipolar disorders
_gvol. 4
_gno. 6
_gp. 412-7
856 4 0 _uhttps://doi.org/10.1034/j.1399-5618.2002.02228.x
_zAvailable from publisher's website
999 _c12321824
_d12321824